Clinicopathologic Characteristics and Prognosis of Xp11.2 Translocation Renal Cell Carcinoma: Multicenter, Propensity Score Matching Analysis
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Genitourinary Cancer"
DOI: 10.1016/j.clgc.2017.04.015
Abstract: Micro‐Abstract We evaluated the clinicopathologic characteristics and prognosis of Xp11.2 translocation renal cell carcinoma (RCC) from a multicenter study. This rare neoplasm had more aggressive clinicopathologic features to involve lymph nodes at diagnosis. The age… read more here.
Keywords: xp11 translocation; prognosis; rcc; clear cell ... See more keywords
PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressiveness
Sign Up to like & getrecommendations! Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-02005-7
Abstract: Programmed death ligand-1 (PD-L1), a promising antitumor target, has proven clinical value against many malignancies. However, the PD-L1 content of Xp11.2 translocation renal cell carcinoma (Xp11.2 RCC) and its correlation with clinical outcomes remain unclear.… read more here.
Keywords: xp11 translocation; xp11 rcc; expression; translocation renal ... See more keywords
Systemic Therapy in Patients With Metastatic Xp11.2 Translocation Renal Cell Carcinoma.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical genitourinary cancer"
DOI: 10.1200/jco.2022.40.6_suppl.341
Abstract: BACKGROUND Xp11.2 translocation renal cell carcinoma (Xp11.2 tRCC) is a unique subtype with poor prognosis, its response to systemic therapy is not fully understood, we evaluated the benefit of systemic therapy in these patients. PATIENTS… read more here.
Keywords: xp11; months months; metastatic xp11; xp11 trcc ... See more keywords
Gene Expression Analysis of Aggressive Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical Stage T1N0M0 to Identify Potential Prognostic and Therapeutic Biomarkers
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10020321
Abstract: Xp11.2 translocation renal cell carcinoma (tRCC), involving transcription factor E3 (TFE3) gene fusions, is a rare and aggressive RCC variant when present in adults and has been recently recognized as a unique entity in RCC.… read more here.
Keywords: cell; xp11; trcc; xp11 trcc ... See more keywords